Did you know?

Nov 8, 2023 · SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November ... UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...946,641. Delayed Quote Nasdaq, November 24, 2023 at 01:00 pm EST. More quotes. Company Profile. SomaLogic, Inc. is a commercial-stage proteomics company. The …SomaLogic Inc Class A SLGC Morningstar Rating Stock XNAS Rating as of Nov 21, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating...Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by ...Oct 4, 2023 · SomaLogic shareholders will receive 1.11 shares of Standard BioTools common stock for each share of SomaLogic common stock owned. Upon the close of the deal, Standard BioTools shareholders will ... Endpoints News — SomaLogic, co-founder of acquired company battle in court over unvested stock News • Jun 29, 2023 Benzinga — Analyst Ratings for ConcentrixThe Company notes that the revised share number in such pro forma tables was determined by multiplying the updated exchange ratio (0.8426) as determined pursuant to the Business Combination Agreement by the number of issued and outstanding shares of SomaLogic common stock prior to consummation of the Business Combination, after …The stock is currently trading at $2.47 and its $5.06 average price target implies ~105% upside potential by the end of this year. (See BFLY stock forecast ) SomaLogic, Inc. ( SLGC )SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in ...Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...SomaLogic, Inc. Warrant (SLGCW) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.SomaLogic, Inc. (NASDAQ:SLGC) Number of Hedge Fund Investors in Q4 2022: 33 SomaLogic, Inc. (NASDAQ:SLGC) is a bioinformatics company whose platforms allow for protein detection, discovery, and ...SomaLogic (Nasdaq: SLGC) is fostering the discovery of effective and safer treatments for patients in need while empowering more accurate diagnosis, prevention, and treatment of disease through the next generation of proteomics. Powered by an industry-leading technology platform comprised of both assay services and diagnostics in …Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.After this action, Taich Adam now owns 238,643 shares of SomaLogic Inc, valued at $50,286 using the latest closing price. Gutierrez Ruben, the General Counsel of SomaLogic Inc, sale 9,211 shares at $2.33 during a trade that took place back on Sep 15, which means that Gutierrez Ruben is holding 110,534 shares at $21,460 based on the most recent ...Get the latest Somalogic Inc (SLGC) stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's financial performance, balance sheet, cash flow, and earnings per share for the fiscal Q2 2023 ended 6/30/23. Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …

Appointed Eliot Lurier, CPA, to Interim Chief Financial Officer. Second Quarter 2023 Financial Results. Revenue for the three months ended June 30, 2023 was $20.5 million, a 45% increase from $14.1 million in the corresponding period of 2022. Excluding Q2 2022 royalty revenue from NEB, revenue grew 55%. Gross margin for the three months ended ...BOULDER, Colo. and SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire ...Nov 8, 2023 · SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November ... The all-time high SomaLogic stock closing price was 14.28 on November 05, 2021. The SomaLogic 52-week high stock price is 3.79, which is 37.8% above the current share price. The SomaLogic 52-week low stock price is 1.73, which is 37.1% below the current share price. The average SomaLogic stock price for the last 52 weeks is 2.55.

See the latest SomaLogic Inc Class A stock price (SLGC:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Oct 4, 2023 · Under the terms of the all-stock deal, SomaLogic investors are to receive 1.11 common shares of Standard BioTools stock for each SomaLogic common share they hold. When the merger closes, SomaLogic ... …

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Filing of certain prospectuses and communications in connec. Possible cause: SomaLogic and Standard BioTools announced on Wednesday that the companie.